Billis Athanase, Guimaraes Marbele S, Freitas Leandro L L, Meirelles Luciana, Magna Luis A, Ferreira Ubirajara
Department of Pathology, School of Medicine, State University of Campinas (Unicamp), Campinas, Brazil.
J Urol. 2008 Aug;180(2):548-52; discussion 552-3. doi: 10.1016/j.juro.2008.04.018. Epub 2008 Jun 11.
At an International Society of Urological Pathology consensus conference in 2005 the Gleason grading system for prostatic carcinoma underwent its first major revision. We compared the concordance of pattern and change of prognostic groups for the conventional and the modified Gleason grading, and checked the discriminative power of the modified Gleason grading.
The grading was based on 172 prostatic needle biopsies of patients subsequently undergoing radical prostatectomy. Four prognostic Gleason grading groups were considered, divided into scores of 2-4, 5-6, 7 and 8-10. To check the discriminative power of the modified Gleason grading we compared the time of biochemical (prostate specific antigen) progression-free outcome according to prognostic groups between standard and revised grading.
The greatest impact of the International Society of Urological Pathology consensus recommendations for Gleason grading was seen on the secondary pattern which had the lowest percentage of concordance and was reflected in a change toward higher Gleason prognostic groups. Of 172 patients in whom the Gleason prognostic group was changed (to higher grades) based solely on the consensus criteria, 46 (26.7%) had higher preoperative prostate specific antigen, more extensive tumors and positive surgical margins, and higher pathological stage. The revised Gleason grading identified in this series a higher number of patients in the aggressive prognostic group Gleason score 8-10 who had a significantly shorter time to biochemical progression-free outcome after radical prostatectomy (log rank p = 0.011).
The findings of this study indicate that the recommendations of the International Society of Urological Pathology are a valuable refinement of the standard Gleason grading system.
2005年国际泌尿病理学会共识会议上,前列腺癌的格里森分级系统经历了首次重大修订。我们比较了传统和改良格里森分级在模式和预后组变化方面的一致性,并检验了改良格里森分级的鉴别能力。
分级基于172例随后接受根治性前列腺切除术患者的前列腺穿刺活检。考虑了四个预后格里森分级组,分为2 - 4分、5 - 6分、7分和8 - 10分。为检验改良格里森分级的鉴别能力,我们比较了标准分级和修订分级下各预后组生化(前列腺特异性抗原)无进展生存时间。
国际泌尿病理学会关于格里森分级的共识建议对次要模式影响最大,其一致性百分比最低,并反映为向更高格里森预后组的转变。在172例仅根据共识标准将格里森预后组上调(至更高分级)的患者中,46例(26.7%)术前前列腺特异性抗原更高、肿瘤范围更广、手术切缘阳性且病理分期更高。本系列研究中,修订后的格里森分级在侵袭性预后组格里森评分8 - 10分中识别出更多患者,这些患者根治性前列腺切除术后生化无进展生存时间显著更短(对数秩检验p = 0.011)。
本研究结果表明,国际泌尿病理学会的建议是对标准格里森分级系统的有价值改进。